Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Filings indexed 570 across all filing types
Latest filing 2022-08-23 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
回购股份方案公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a share repurchase plan by the company 云南生物谷药业股份有限公司. It includes specifics about the repurchase purpose, pricing, quantity, funding source, implementation period, impact on shareholding structure, management analysis on financial impact, authorization by the shareholders, and risk factors related to the repurchase. The document is not a financial report, earnings release, or management discussion but a formal announcement of the company's plan to buy back its own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements and related details. The document length and content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2022-08-23 Chinese
第四届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the fourth board of directors of Yunnan Shengwu Valley Pharmaceutical Co., Ltd. It details the meeting attendance, agenda items, voting results, and references other announcements for detailed content. The document does not contain full financial statements or detailed reports but rather summarizes board decisions and refers to other filings for full reports. This type of document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 3570 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the classification is MANG with high confidence.
2022-08-23 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or Interim Report for the year 2022. It contains detailed financial data including income, expenses, assets, liabilities, profit and loss, and operational analysis for the period from January 1, 2022 to June 30, 2022. The document includes sections such as company overview, accounting data, business overview, risk factors, and financial statements. It explicitly states it is a half-year report and includes comprehensive financial statements and analysis, not just an announcement or summary. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-23 Chinese
独立董事关于第四届董事会第九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several board meeting agenda items, including a share repurchase plan and project delay. It references the company's board meeting and legal compliance but does not contain financial statements or detailed financial data. The document is a formal opinion related to board decisions rather than a full management report or financial report. It is not a report publication announcement or certification but a board/management information type document announcing board-related decisions and opinions. Therefore, the most appropriate classification is Board/Management Information (MANG).
2022-08-23 Chinese
关于收到受理案件通知书的公告
Legal Proceedings Report Classification · 100% confidence The document is a public announcement from a company regarding the receipt of a legal case acceptance notice from a court. It details the case number, parties involved, legal procedural information, and instructions related to the litigation process. There is no financial data, no report attached or referenced as being published, and no mention of financial results or corporate governance changes. The content is clearly about a legal proceeding update. Therefore, the document fits the category of Legal Proceedings Report (LTR). The document length is short and focused solely on legal matters, not a full report or announcement of a report publication.
2022-08-17 Chinese
关于触发稳定股价措施启动条件的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company regarding the triggering of conditions for stock price stabilization measures. It details the criteria for initiating these measures, the specific triggering event, and the company's planned response. The content focuses on regulatory compliance and shareholder information about stock price stabilization, not on financial results, management changes, or other report types. The document length is short (940 characters), and it is an announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-08-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.